Secondary Hyperparathyroidism Treatment Market Outlook: 5.5% CAGR Growth Through 2031
According to a newly published market research report by 24LifeSciences, global secondary hyperparathyroidism treatment market was valued at USD 3.17 billion in 2024 and is projected to reach USD 4.58 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.5% during the forecast period 20252031. Secondary hyperparathyroidism is an endocrine disorder characterized by...
0 Comments 0 Shares 97 Views 0 Reviews